General Information of Drug-Metabolizing Enzyme (DME ID: DME0548)
DME Name Dimethylarginine dimethylaminohydrolase 1 (DDAH1), Homo sapiens DME Info
UniProt ID
DDAH1_HUMAN
EC Number    EC: 3.5.3.18     (Click to Show/Hide the Complete EC Tree)
Hydrolases
Carbon-nitrogen hydrolase
Linear amidine hydrolase
EC: 3.5.3.18
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification Healthy
               ICD-11: Healthy Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Non-coding RNA regulation
                            hsa-miR-210-3p Health Suppression
miRBase ID
MIMAT0000267
Interaction Name hsa-miR-210-3p--DDAH1 regulation [1]
Studied Cell Lines HEK293 cell line
Description hsa-miR-210-3p is reported to suppress DDAH1 mRNA translation by binding to the 3' untranslated region (3'UTR) of DDAH1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1.
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2A00 Brain cancer Click to Show/Hide the Full List of HOSPPI:        2 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Brain neuroblastoma Significant hypomethylation
Interaction Name DNMT-DDAH1 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 2.19E-21; delta-beta: -6.14E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the DDAH1 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. As a result, the interaction between DNMT and DDAH1 can significantly affect the drug-metabolizing process of Dimethylarginine dimethylaminohydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
                            DNA methyltransferase (DNMT) Vestibular melanotic schwannoma Moderate hypomethylation
Interaction Name DNMT-DDAH1 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Moderate hypomethylation
p-value: 5.66E-05; delta-beta: -2.18E-01
Description DNA methyltransferase (DNMT) is reported to moderatly hypo-methylate the DDAH1 gene, which leads to a moderatly increased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. As a result, the interaction between DNMT and DDAH1 can moderatly affect the drug-metabolizing process of Dimethylarginine dimethylaminohydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2C25 Lung cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Non-coding RNA regulation
                            hsa-miR-21-5p Lung cancer Suppression
miRBase ID
MIMAT0000076
Interaction Name hsa-miR-21-5p--DDAH1 regulation [2]
Studied Cell Lines A549 cell line
Description hsa-miR-21-5p is reported to suppress DDAH1 mRNA translation by binding to the 3' untranslated region (3'UTR) of DDAH1 mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1.
      ICD Disease Classification 11 Circulatory system diseases
               ICD-11: BD51 Arterial aneurysm Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Arterial aneurysm Significant hypermethylation
Interaction Name DNMT-DDAH1 interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypermethylation
p-value: 3.44E-02; delta-beta: 4.12E-01
Description DNA methyltransferase (DNMT) is reported to significantly hyper-methylate the DDAH1 gene, which leads to a significantly decreased expression of the drug-metabolizing enzyme Dimethylarginine dimethylaminohydrolase 1. As a result, the interaction between DNMT and DDAH1 can significantly affect the drug-metabolizing process of Dimethylarginine dimethylaminohydrolase 1.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
References
1 An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem. 2009 Dec 11;284(50):35134-43.
2 Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer. Mol Pharm. 2016 Feb 1;13(2):653-62.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.